8-K
filed May 2, 2025, 7:59 PM ET
CIK 0001289850
M&A
confidence high
sentiment neutral
materiality 0.90
NeuroMetrix, Inc.: M&A transaction — NeuroMetrix completes merger with electroCore; shareholders receive $4.49/share plus CVRs
NeuroMetrix, Inc.
- Merger closed on May 1, 2025; shareholders receive $4.49 per share cash plus contingent value rights.
- CVRs tied to future proceeds from Quell product line and asset purchase agreements with Fukuda Denshi and Alera/Impulse.
- Common stock to be delisted from Nasdaq; registration under Section 12(g) to be terminated.
- Board and officers replaced; Dan Goldberger becomes CEO, Joshua Lev CFO of surviving corporation.
- Employee Stock Purchase Plan terminated effective May 1, 2025.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Joshua Horowitz departed as Director at NeuroMetrix, Inc..
- Action
- ceased
- Role
- Director
Exact text from the filing
In connection with the consummation of the Merger, each of Shai N. Gozani, David Van Avermaete, David E. Goodman, Joshua Horowitz and Nancy E. Katz ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
David Van Avermaete departed as Director at NeuroMetrix, Inc..
- Action
- ceased
- Role
- Director
Exact text from the filing
In connection with the consummation of the Merger, each of Shai N. Gozani, David Van Avermaete, David E. Goodman, Joshua Horowitz and Nancy E. Katz ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Shai N. Gozani departed as Director at NeuroMetrix, Inc..
- Action
- ceased
- Role
- Director
Exact text from the filing
In connection with the consummation of the Merger, each of Shai N. Gozani, David Van Avermaete, David E. Goodman, Joshua Horowitz and Nancy E. Katz ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Dan Goldberger was appointed as Chief Executive Officer at NeuroMetrix, Inc..
- Action
- became
- Role
- Chief Executive Officer
Exact text from the filing
Dan Goldberger became the Chief Executive Officer of the Surviving Corporation
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Dan Goldberger was appointed as Director at NeuroMetrix, Inc..
- Action
- became
- Role
- Director
Exact text from the filing
At the Effective Time, in connection with the consummation of the Merger, and pursuant to the Merger Agreement each of Dan Goldberger and Joshua Lev (the directors of Merger Sub immediately prior to the Effective Time) became the directors of the Surviving Corporation in lieu of the Company’s existing directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Joshua Lev was appointed as Director at NeuroMetrix, Inc..
- Action
- became
- Role
- Director
Exact text from the filing
At the Effective Time, in connection with the consummation of the Merger, and pursuant to the Merger Agreement each of Dan Goldberger and Joshua Lev (the directors of Merger Sub immediately prior to the Effective Time) became the directors of the Surviving Corporation in lieu of the Company’s existing directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Joshua Lev was appointed as Chief Financial Officer at NeuroMetrix, Inc..
- Action
- became
- Role
- Chief Financial Officer
Exact text from the filing
Joshua Lev became the Chief Financial Officer of the Surviving Corporation
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Nancy E. Katz departed as Director at NeuroMetrix, Inc..
- Action
- ceased
- Role
- Director
Exact text from the filing
In connection with the consummation of the Merger, each of Shai N. Gozani, David Van Avermaete, David E. Goodman, Joshua Horowitz and Nancy E. Katz ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
David E. Goodman departed as Director at NeuroMetrix, Inc..
- Action
- ceased
- Role
- Director
Exact text from the filing
In connection with the consummation of the Merger, each of Shai N. Gozani, David Van Avermaete, David E. Goodman, Joshua Horowitz and Nancy E. Katz ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.4
NeuroMetrix, Inc.: The Surviving Corporation adopted the Fourth Amended and Restated Certificate of Incorporation in connection with the Merger.
- Change
- charter amendment
Exact text from the filing
At the Effective Time and in connection with the Merger, the Surviving Corporation adopted the Fourth Amended and Restated Certificate of Incorporation, in the form attached hereto as Exhibit 3.1(the “ Amended and Restated Certificate ”).
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.4
NeuroMetrix, Inc.: The Surviving Corporation adopted Amended and Restated Bylaws in connection with the Merger.
- Change
- bylaw amendment
Exact text from the filing
At the Effective Time and in connection with the Merger, the Surviving Corporation adopted the Amended and Restated Bylaws, in the form attached hereto as Exhibit 3.2 (the “ Amended and Restated Bylaws ”).
View on SEC.gov
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
NeuroMetrix, Inc. underwent a change of control involving electroCore, Inc. for $4.49 per share in cash plus one contingent value right (closed 2025-05-01).
- Action
- change of control
- Counterparty
- electroCore, Inc.
- Consideration
- $4.49 per share in cash plus one contingent value right
- Closing
- 2025-05-01
Exact text from the filing
the “ Merger Consideration ”). In accordance with the Merger Agreement, the Per Share Cash Consideration was determined by the Company and Parent to be in the amount of $4.49 per share of Company Common Stock. Each share of preferred stock, par value $0.001 per share, of the Company (the “ Company Preferred Stock ”) outstanding immediately prior to the
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.